Home  >  Products  >  KLK13 (kallikrein-related peptidase 13) Blocking Peptide (the middle region of KLK13)(100ug)
KLK13 (kallikrein-related peptidase 13) Blocking Peptide (the middle region of KLK13)(100ug)

KLK13 (kallikrein-related peptidase 13) Blocking Peptide (the middle region of KLK13)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KLK13 Antibody(ARP55295_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP55295
Size: 100ug
Weight: 29kDa
Gene: 26085
Format: Lyophilized powder
Target: Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined.
Alternative names: DKFZP586J1923; KLK-L4; KLKL4
See Full Product Listings >